5-(2-amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors. 2012

Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
Nerviano Medical Sciences srl, Business Unit Oncology, Viale Pasteur 10, 20014 Nerviano, (MI), Italy.

The discovery and characterization of two new chemical classes of potent and selective Polo-like kinase 1 (PLK1) inhibitors is reported. For the most interesting compounds, we discuss the biological activities, crystal structures and preliminary pharmacokinetic parameters. The more advanced compounds inhibit PLK1 in the enzymatic assay at the nM level and exhibit good activity in cell proliferation on A2780 cells. Furthermore, these compounds showed high levels of selectivity on a panel of unrelated kinases, as well as against PLK2 and PLK3 isoforms. Additionally, the compounds show acceptable oral bioavailability in mice making these inhibitors suitable candidates for further in vivo activity studies.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004798 Enzymes Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified. Biocatalyst,Enzyme,Biocatalysts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
February 2007, Bioorganic & medicinal chemistry letters,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
July 2007, Bioorganic & medicinal chemistry letters,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
July 2019, Bioorganic & medicinal chemistry letters,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
October 2017, ACS medicinal chemistry letters,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
November 2010, Acta crystallographica. Section E, Structure reports online,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
December 2011, Acta crystallographica. Section E, Structure reports online,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
March 2010, Journal of medicinal chemistry,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
December 2022, European journal of medicinal chemistry,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
June 2019, Bioorganic & medicinal chemistry,
Michele Caruso, and Barbara Valsasina, and Dario Ballinari, and Jay Bertrand, and Maria Gabriella Brasca, and Marina Caldarelli, and Paolo Cappella, and Francesco Fiorentini, and Laura M Gianellini, and Alessandra Scolaro, and Italo Beria
December 1984, Journal of medicinal chemistry,
Copied contents to your clipboard!